Logo image of WALD

WALDENCAST PLC-A (WALD) Stock Fundamental Analysis

NASDAQ:WALD - Nasdaq - JE00BPG99318 - Common Stock - Currency: USD

1.64  +0.03 (+1.86%)

After market: 1.64 0 (0%)

Fundamental Rating

2

Overall WALD gets a fundamental rating of 2 out of 10. We evaluated WALD against 35 industry peers in the Personal Care Products industry. Both the profitability and financial health of WALD have multiple concerns. While showing a medium growth rate, WALD is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year WALD has reported negative net income.
WALD had a negative operating cash flow in the past year.
WALD had negative earnings in each of the past 5 years.
In the past 5 years WALD always reported negative operating cash flow.
WALD Yearly Net Income VS EBIT VS OCF VS FCFWALD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

WALD has a Return On Assets of -4.35%. This is in the lower half of the industry: WALD underperforms 65.71% of its industry peers.
WALD has a Return On Equity of -6.41%. This is comparable to the rest of the industry: WALD outperforms 45.71% of its industry peers.
Industry RankSector Rank
ROA -4.35%
ROE -6.41%
ROIC N/A
ROA(3y)-7.89%
ROA(5y)-6.57%
ROE(3y)-13.02%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
WALD Yearly ROA, ROE, ROICWALD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 0 0 0 0

1.3 Margins

The Gross Margin of WALD (70.01%) is better than 62.86% of its industry peers.
The Profit Margin and Operating Margin are not available for WALD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 70.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
WALD Yearly Profit, Operating, Gross MarginsWALD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 50 -50

More info and screens

1

2. Health

2.1 Basic Checks

WALD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for WALD has been increased compared to 1 year ago.
Compared to 1 year ago, WALD has a worse debt to assets ratio.
WALD Yearly Shares OutstandingWALD Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
WALD Yearly Total Debt VS Total AssetsWALD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 0.10, we must say that WALD is in the distress zone and has some risk of bankruptcy.
WALD has a worse Altman-Z score (0.10) than 85.71% of its industry peers.
A Debt/Equity ratio of 0.21 indicates that WALD is not too dependend on debt financing.
WALD has a Debt to Equity ratio (0.21) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z 0.1
ROIC/WACCN/A
WACC10.47%
WALD Yearly LT Debt VS Equity VS FCFWALD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

WALD has a Current Ratio of 1.35. This is a normal value and indicates that WALD is financially healthy and should not expect problems in meeting its short term obligations.
WALD's Current ratio of 1.35 is on the low side compared to the rest of the industry. WALD is outperformed by 62.86% of its industry peers.
A Quick Ratio of 0.66 indicates that WALD may have some problems paying its short term obligations.
WALD's Quick ratio of 0.66 is on the low side compared to the rest of the industry. WALD is outperformed by 71.43% of its industry peers.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 0.66
WALD Yearly Current Assets VS Current LiabilitesWALD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

5

3. Growth

3.1 Past

WALD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 60.66%, which is quite impressive.
Looking at the last year, WALD shows a very strong growth in Revenue. The Revenue has grown by 25.55%.
EPS 1Y (TTM)60.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60.66%
Revenue 1Y (TTM)25.55%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-66.95%

3.2 Future

WALD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 49.31% yearly.
The Revenue is expected to grow by 23.60% on average over the next years. This is a very strong growth
EPS Next Y-77.23%
EPS Next 2Y-19.82%
EPS Next 3Y66.6%
EPS Next 5Y49.31%
Revenue Next Year13.12%
Revenue Next 2Y14.48%
Revenue Next 3Y30.05%
Revenue Next 5Y23.6%

3.3 Evolution

WALD Yearly Revenue VS EstimatesWALD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
WALD Yearly EPS VS EstimatesWALD Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 0.4 0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

WALD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year WALD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WALD Price Earnings VS Forward Price EarningsWALD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, WALD is valued a bit more expensive than the industry average as 60.00% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 54.14
WALD Per share dataWALD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

A more expensive valuation may be justified as WALD's earnings are expected to grow with 66.60% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-19.82%
EPS Next 3Y66.6%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for WALD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WALDENCAST PLC-A

NASDAQ:WALD (8/8/2025, 4:02:24 PM)

After market: 1.64 0 (0%)

1.64

+0.03 (+1.86%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)05-13 2025-05-13/amc
Earnings (Next)08-18 2025-08-18
Inst Owners20.22%
Inst Owner Change0.36%
Ins Owners2.68%
Ins Owner ChangeN/A
Market Cap201.74M
Analysts80
Price Target4.06 (147.56%)
Short Float %2.7%
Short Ratio7.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-177.53%
Min EPS beat(2)-239.37%
Max EPS beat(2)-115.69%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)0.1%
Min Revenue beat(2)0.06%
Max Revenue beat(2)0.14%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-18.44%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-94.57%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.3%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.49%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.74
P/FCF N/A
P/OCF N/A
P/B 0.3
P/tB N/A
EV/EBITDA 54.14
EPS(TTM)-0.39
EYN/A
EPS(NY)-0.37
Fwd EYN/A
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS2.23
BVpS5.38
TBVpS-1.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.35%
ROE -6.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 70.01%
FCFM N/A
ROA(3y)-7.89%
ROA(5y)-6.57%
ROE(3y)-13.02%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA 21.22
Cap/Depr 5.02%
Cap/Sales 1.1%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.35
Quick Ratio 0.66
Altman-Z 0.1
F-Score5
WACC10.47%
ROIC/WACCN/A
Cap/Depr(3y)5.17%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.18%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)60.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60.66%
EPS Next Y-77.23%
EPS Next 2Y-19.82%
EPS Next 3Y66.6%
EPS Next 5Y49.31%
Revenue 1Y (TTM)25.55%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-66.95%
Revenue Next Year13.12%
Revenue Next 2Y14.48%
Revenue Next 3Y30.05%
Revenue Next 5Y23.6%
EBIT growth 1Y34.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year290.23%
EBIT Next 3Y101.29%
EBIT Next 5Y71.59%
FCF growth 1Y62.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y70.38%
OCF growth 3YN/A
OCF growth 5YN/A